Prostate Cancer Canada Translational Acceleration Grant awarded to Drs. Rennie, Cherkasov and Tomlinson-Guns

29/09/14

September 26, 2014 - Prostate Cancer Canada today annouced the results of their funding decision in their Translation Acceleration Grant competition TAG2: Novel Therapeutics for Advanced Disease.  This funding is for groups studying novel therapeutics and treatment options for metastatic and castrate-resistant prostate cancer, for  projects aimed at eliminating advanced disease from affected men. Co-lead by Drs. Paul Rennie, Art Cherkasov & Emma Tomlinson-Guns, the project "Pre-clinical development of the next-generation anti-androgens for the treatment of drug-resistant and advanced prostate cancer" is one of only two grants awarded.  The three-year grant is for $1,463,090 starting on October 1, 2014.Click here to read the Prostate Cancer Canada press release.

News

Jul 26 2017

Dr. Zoubeidi awarded PCC-Movember Translation Acceleration Grant

July 26, 2017 - TORONTO, ON - Continuing their longstanding tradition of partnering to fund high quality Canadian prostate cancer research, Prostate Cancer Canada (PCC) and The Movember Foundation today announced two new projects with very real potential to make a tangible difference in the lives of men living with aggressive forms of prostate cancer.

Read more